Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01218087 · ClinicalTrials.gov registry record · NA

Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU

A NA study, sponsored by Boston Children's Hospital.

Terminated
Registry status
NA
Development phase
88
Enrollment target

NCT01218087: Clinical Trial NA study, sponsored by Boston Children's Hospital.

NCT01218087 is a NA study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01218087, a NA study, was terminated before completion, sponsored by Boston Children's Hospital.

TERMINATED
Registry status
NA
Development phase
88 participants
Enrollment target

Study Summary

Many hospitalized infants can develop a flattening of the back or sides of their head. This condition develops gradually when an infant's head rests on a firm or semi-firm surface for a prolonged period of time. Premature infants are more likely to have a positional head shape deformity because they may spend longer periods of time in a crib. Infants participating in this study will be randomly assigned to either standard treatment, which is a moldable positioner device, or to a cranial cup device and moldable positioner for positioning. The purpose of this prospective single-blinded randomized clinical trial will be to evaluate the effectiveness of the cranial cup in preventing positional head shape deformity in the NICU patient population.

Primary Outcome

Cranial abnormality measurements were obtained at hospital discharge by orthotists blinded to the study group assignment. Cranial abnormalities include both cranial index measures and cranial symmetry measures. Cranial index (normal measurement between 73%-85%) was obtained dividing the head width (M-L) by length (A-P) then multiplying it by 100%. Cranial symmetry (normal measurement of\<8mm) was obtained by calculating the difference in the right and left anterior-posterior measures.

Interventions

  • DEVICE Cranial cup device and Moldable positioner
  • DEVICE Moldable positioner device

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2010-04
Est. Completion 2012-07
Phase NA
Boston Children's Hospital

462 total trials

Why NCT01218087 stopped before completion

NCT01218087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Cranial cup device and Moldable positioner is the first listed.

NCT01218087 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01218087 about?

NCT01218087 is a clinical study titled "Cranial Cup Use for the Prevention of Positional Head Shape Deformity in the NICU". Many hospitalized infants can develop a flattening of the back or sides of their head. This condition develops gradually when an infant's head rests on a firm or semi-firm surface for a prolonged period of time. Premature infants are more likely to have a positional head shape deformity because they...

What is the current status of trial NCT01218087?

This trial is currently terminated. It is a NA study. The enrollment target is 88 participants. The study started on 2010-04. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01218087?

The interventions under investigation include: Cranial cup device and Moldable positioner (DEVICE), Moldable positioner device (DEVICE).

Who is sponsoring clinical trial NCT01218087?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01218087's enrollment target sits among peer trials

88 972nd of 2000 higher than 1,027 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01218087, the US trial registry maintained by the National Library of Medicine. NCT01218087 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.